Skip to main content
. 2024 Jun 28;9(7):103624. doi: 10.1016/j.esmoop.2024.103624

Table 3.

Association of current and preferred exercise discussion in patients with cancera

Current exercise discussionb
Preferred exercise discussionb
ORc 95% CIc P valuec ORc 95% CIc P valuec
Sex
 Female (reference) 1.000 1.000
 Male 1.562 (0.93-2.61) 0.089 1.709 (0.97-3.01) 0.064
Age (years)
 <65 (reference) 1.000 1.000
 ≥65 1.025 (0.58-1.82) 0.933 1.339 (0.73-2.45) 0.344
Body mass index (kg/m2)
 Underweight (reference) 1.000 1.000
 Normal weight 1.929 (0.57-6.51) 0.290 0.804 (0.22-2.92) 0.741
 Overweight 2.350 (0.67-8.20) 0.180 0.656 (0.17-2.47) 0.532
 Obese 2.313 (0.62-8.61) 0.211 1.724 (0.40-7.37) 0.463
Education
 Up to age 14 years (reference) 1.000 1.000
 Beyond age 14 years 1.377 (0.86-2.20) 0.179 1.778 (1.06-2.99) 0.030
Marital status
 Married (reference) 1.000 1.000
 Single 0.643 (0.33-1.25) 0.194 1.151 (0.51-2.60) 0.735
 Divorced 0.950 (0.44-2.08) 0.898 1.013 (0.42-2.46) 0.978
 Widowed 0.759 (0.29-1.97) 0.572 0.638 (0.23-1.75) 0.383
Occupational status
 Retired (reference) 1.000 1.000
 Homemaker 1.150 (0.49-2.68) 0.746 0.888 (0.36-2.18) 0.796
 Part-time 4.559 (1.63-12.72) 0.004 17.786 (2.18-145.03) 0.007
 Full-time 2.024 (1.06-3.88) 0.034 2.036 (0.99-4.17) 0.052
 Other 1.438 (0.36-5.71) 0.606 6.430 (0.70-59.01) 0.100
Income adequacy
 Inadequate (reference) 1.000 1.000
 Adequate 0.927 (0.58-1.48) 0.751 0.860 (0.51-1.45) 0.569
Physical activity frequency
 <1 time/week (reference) 1.000 1.000
 1-2 times/week 1.551 (0.90-2.68) 0.115 1.758 (0.94-3.28) 0.076
 >2 times/week 1.713 (0.99-2.94) 0.050 1.059 (0.59-1.91) 0.848
Tumor sited
 Breast (reference) 1.000 1.000
 Lung 3.508 (1.36-9.05) 0.009 0.623 (0.20-1.94) 0.414
 Colorectal 2.308 (0.74-7.25) 0.152 1.190 (0.27-5.30) 0.820
 Upper gastrointestinal area 0.982 (0.39-2.46) 0.969 0.776 (0.25-2.37) 0.656
 Urogenital 2.322 (0.61-8.90) 0.219 0.479 (0.10-2.30) 0.358
 Other 0.765 (0.23-2.53) 0.660 0.406 (0.10-1.67) 0.211
Stage of disease
 Remission (reference) 1.000 1.000
 Early 1.135 (0.48-2.70) 0.775 1.753 (0.62-4.96) 0.290
 Advanced 0.602 (0.28-1.28) 0.188 0.612 (0.26-1.46) 0.270
 Metastatic 0.677 (0.34-1.36) 0.272 0.696 (0.31-1.58) 0.385
 Unknown 0.569 (0.25-1.28) 0.174 0.546 (0.21-1.40) 0.207
Chemotherapy
 No (reference) 1.000 1.000
 Yes 0.892 (0.51-1.56) 0.687 0.864 (0.46-1.61) 0.647
Surgery
 No (reference) 1.000 1.000
 Yes 0.851 (0.50-1.44) 0.548 1.348 (0.74-2.47) 0.335
Radiotherapy
 No (reference) 1.000 1.000
 Yes 1.209 (0.72-2.04) 0.475 1.007 (0.56-1.81) 0.982
Hormonotherapy
 No (reference) 1.000 1.000
 Yes 1.071 (0.42-2.76) 0.888 2.458 (0.67-8.98) 0.174
Other therapies
 No (reference) 1.000 1.000
 Yes 0.774 (0.417-1.43) 0.415 1.410 (0.72-2.76) 0.315
Adherence to guideline
 No (reference) 1.000 1.000
 Yes 1.221 (0.55-2.71) 0.624 1.471 (0.58-3.6) 0.420
Leisure Score Index
 <24 (reference) 1.000 1.000
 ≥24 1.415 (0.55-3.68) 0.476 1.002 (0.34-2.99) 0.997
Time from diagnosis
 ≤30 m (reference) 1.000 1.000
 >30 m 1.295 (0.78-2.15) 0.315 1.021 (0.58-1.80) 0.942

CI, confidence interval; OR, odds ratio.

a

Current and preferred exercise discussion classified as yes, oncologist-initiated discussion/yes, initiated by me versus no.

b

Each variable was mutually adjusted for the following variables if not otherwise specified: sex (male, female); age (<65 years versus ≥65 years); education (≥high school versus <lower than high school); patient’s address (outside the city, city dweller); perceived income adequacy (adequate versus nonadequate); marital status (married, unmarried, divorced, widow); occupational status (retired, stay at home, part-time employed, full-time employed, other); frequency of sweating-inducing activity (<1 time/week; 1-2 times/week; >2 times/week); adherence to guidelines (yes versus no); Leisure Score Index (<24 versus ≥24); tumor site (breast, lung, colorectal, upper gastrointestinal area, urogenital, other); stage of the disease (remission, early, advanced, metastatic, unknown); chemotherapy (yes versus no); surgery (yes versus no); radiotherapy (yes versus no); hormone therapy (yes versus no); other treatments (yes versus no); treatment status (ended, incoming, ongoing, undefined); time from diagnosis (≤30 months, >30 months).

c

OR and CI and P value from the logistic regression model.

d

Tumor sites with <10 patients are classified as ‘other’.